Page last updated: 2024-11-10

hamacanthine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hamacanthine A: a dihydropyrazinonediylbis(indole) alkaloid from deep-water marine sponge Hamacantha sp.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hamacanthin A : A member of the class of pyrazinones that is 5,6-dihydropyrazin-2(1H)-one substituted at positions 3 and 6 by 6-bromo-1H-indol-3-yl groups. It is an antifungal drug isolated from deep water marine sponge Hamacantha sp. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3037568
CHEMBL ID219456
MeSH IDM0241140

Synonyms (5)

Synonym
160098-92-0
hamacanthine a
hamacanthin a
CHEMBL219456
(2s)-2,5-bis(6-bromo-1h-indol-3-yl)-2,3-dihydro-1h-pyrazin-6-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID337905Antifungal activity against Cryptococcus neoformans ATCC 32045 after 48 hrs by broth microdilution method1994Journal of natural products, Oct, Volume: 57, Issue:10
Hamacanthins A and B, new antifungal bis indole alkaloids from the deep-water marine sponge, Hamacantha sp.
AID274722Cytotoxicity against human HCT15 cell line2007Journal of natural products, Jan, Volume: 70, Issue:1
Bisindole alkaloids of the topsentin and hamacanthin classes from a marine sponge Spongosorites sp.
AID337906Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs by broth microdilution method1994Journal of natural products, Oct, Volume: 57, Issue:10
Hamacanthins A and B, new antifungal bis indole alkaloids from the deep-water marine sponge, Hamacantha sp.
AID274719Cytotoxicity against human SK-OV-3 cell line2007Journal of natural products, Jan, Volume: 70, Issue:1
Bisindole alkaloids of the topsentin and hamacanthin classes from a marine sponge Spongosorites sp.
AID274718Cytotoxicity against human A549 cell line2007Journal of natural products, Jan, Volume: 70, Issue:1
Bisindole alkaloids of the topsentin and hamacanthin classes from a marine sponge Spongosorites sp.
AID744543Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by CLSI method2013European journal of medicinal chemistry, May, Volume: 63Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
AID337674Antifungal activity against Candida albicans ATCC 44506 after 24 hrs by broth microdilution method1994Journal of natural products, Oct, Volume: 57, Issue:10
Hamacanthins A and B, new antifungal bis indole alkaloids from the deep-water marine sponge, Hamacantha sp.
AID744544Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method2013European journal of medicinal chemistry, May, Volume: 63Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
AID274721Cytotoxicity against human XF498 cell line2007Journal of natural products, Jan, Volume: 70, Issue:1
Bisindole alkaloids of the topsentin and hamacanthin classes from a marine sponge Spongosorites sp.
AID274720Cytotoxicity against human SK-MEL-2 cell line2007Journal of natural products, Jan, Volume: 70, Issue:1
Bisindole alkaloids of the topsentin and hamacanthin classes from a marine sponge Spongosorites sp.
AID744538Antibacterial activity against Bacillus subtilis by CLSI method2013European journal of medicinal chemistry, May, Volume: 63Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]